HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malignant ovarian germ cell tumor in King Chulalongkorn Memorial Hospital.

AbstractOBJECTIVES:
To determine the frequency, characteristics, treatment and outcome of patients with malignant ovarian germ cell tumor (MOGCT) in King Chulalongkorn Memorial Hospital during the period January 1992 - December 2000.
STUDY DESIGN:
Retrospective descriptive study
MATERIAL AND METHOD:
All patients with malignant ovarian germ cell tumor in King Chulalongkorn Memorial Hospital during the period January 1992 - December 2000 were analyzed by the characteristics of patients, treatment and outcome.
RESULTS:
Sixty-six patients with MOGCT were demonstrated in that period with a mean age of 22.6 years old. Most of the patients were nulliparous and premenopausal status. Primary surgery was done in all patients. Forty-two patients (63.6%) received conservative surgery. Eight patients received no adjuvant treatment after surgery due to stage 1A dysgerminoma and immature teratoma stage I grade I. Fifty-six patients received chemotherapy for adjuvant treatment. VAC regimen was given in 27 cases (40.9%) and PVB regimen was given in 25 cases (37.9%). Salvage therapy in the patients with persistent and recurrent disease was treated in 9 patients, who received a platinum-base of regimen. Two-year survival was 88% with the median time to follow up 24 months. Overall five-year survival in the present study was 85%.
CONCLUSION:
MOGCT in King Chulalongkorn Memorial Hospital had clinical characteristics similar to other studies in malignant ovarian germ cell tumor Treatment by VAC regimen still has benefit in selected group.
AuthorsRuangsak Lertkhachonsuk, Wichai Termrungruanglert, Apichai Vasuratna, Tul Sittisomwong, Pongkasem Worasethsin, Damrong Tresukosol
JournalJournal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai) Vol. 88 Suppl 4 Pg. S124-8 (Sep 2005) ISSN: 0125-2208 [Print] Thailand
PMID16623016 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Chemotherapy, Adjuvant
  • Child
  • Female
  • Hospitalization (statistics & numerical data)
  • Hospitals, Urban (statistics & numerical data)
  • Humans
  • Incidence
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal (epidemiology, physiopathology, surgery)
  • Ovarian Neoplasms (epidemiology, physiopathology, surgery)
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Salvage Therapy
  • Survival Analysis
  • Thailand (epidemiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: